Skip to content
OpenCapital
Get started

Catalyst Pharmaceutical CPRX EBIT

EBIT at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
$44.96M-95.4%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
-$54.12M-17.7%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
-$4.62M-124%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-$125.28M-2.4%
Scholar Rock logo
Scholar RockSRRK
-$102.02M-32.3%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$141.77M+41.3%

Other financials

Income statement

See full
Revenue$149.4M+5.6%
Gross profit$134.9M+9.2%
Operating income$73.2M+15.6%
Net income$63.7M+12.3%
EPS (diluted)$0.50+11.1%

Balance sheet

See full
Cash & equivalents$755.9M+30.2%
Total debt$2.7M-13.3%
Total equity$1.0B+27.5%
Total assets$1.1B+26.3%

Cash flow

See full
Operating cash flow$59.6M-0.8%
CapEx$27.0K—
Free cash flow$59.6M-0.8%

Valuation

See full
Market cap$3.84B+2.7%
Enterprise value$3.09B-4.1%
P/E17.4×-1.6×
P/S6.4×-0.6×

Profitability

See full
Gross margin86%-0.2pp
Operating margin44.8%+1.6pp
Net margin37.1%+0.2pp
FCF margin34.9%-15.2pp

Returns & leverage

See full
Return on equity24.5%-4.6pp
Debt / equity0×0.0×
Current ratio7.1×+1.0×

Where this comes from

Calculated from Catalyst Pharmaceutical’s reported figures.

$73.2Moperating income+$84.2Mincome before tax=$73.23M

Plus components not separately reported this period.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Catalyst Pharmaceutical's EBIT?
Catalyst Pharmaceutical (CPRX) reported EBIT of $73.23M in Q1 2026.
How has Catalyst Pharmaceutical's EBIT changed year-over-year?
Catalyst Pharmaceutical's EBIT increased by 15.6% year-over-year, from $63.37M to $73.23M.
What is the long-term trend for Catalyst Pharmaceutical's EBIT?
Over 4 years (2021 to 2025), Catalyst Pharmaceutical's EBIT has grown at a 48.9% compound annual growth rate (CAGR), from $52.39M to $257.78M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.